[HTML][HTML] Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, SA Beg, J Lai… - JCI Insight, 2020 - escholarship.org
BACKGROUNDThe relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODSWe …

[PDF][PDF] Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - …, 2020 - pdfs.semanticscholar.org
BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI …, 2020 - pure.johnshopkins.edu
BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

[PDF][PDF] Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI Insight, 2020 - par.nsf.gov
BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI …, 2020 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDThe relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODSWe …

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI Insight, 2020 - europepmc.org
BACKGROUND The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

[HTML][HTML] Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI …, 2020 - Am Soc Clin Investig
BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …

[HTML][HTML] Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai… - JCI …, 2020 - Am Soc Clin Investig
BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time
during effective antiretroviral therapy (ART) have not been fully characterized. METHODS …